This document provides guidance based on scientific evidence regarding quarantine and testing of travellers in EU/EEA countries in the context of the emergence of SARS-CoV-2 variants of concern (VOCs).
For 2022, 20 European Union/European Economic Area (EU/EEA) countries reported 3 650 cases of tick-borne encephalitis (TBE), 3 516 (96.3%) of which were confirmed.
This document aims to support countries in designing after-action reviews (AARs) of the public health response to COVID-19. It has been designed to draw upon pre-existing ECDC guidance and follows a methodological approach combining interactive workshops and interviews. The Annexes feature practical implementation tools.
The purpose of this document is to provide an initial illustration of how the COVID-19 response could unfold in the vaccination era, given the emergence and replacement of the predominant strain with a novel, more transmissible variant.
This report provides an updated overview on the progress of national COVID-19 vaccination strategies and deployment in European Union/European Economic Area (EU/EEA) countries, including updates on overall vaccine uptake and uptake by target group and vaccination strategies and policies.
The aim of this document is to provide an overview of major aspects of testing, contact tracing, contact identification and contact follow-up in school settings within the EU/EEA countries and the United Kingdom (UK).